FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to compounds applicable in medicine corresponding to general formula I, or pharmaceutically acceptable salts thereof:
[Formula I],
where X is -CH2; Y is -CH2 or -O-; m is equal to 1; R1 is C1-C4alkyl; R2 represents halogen, C1-C3alkyl, C2-C3alkenil, C1-C3 alkoxy, -OCF3 or -SR5, where each of at least one hydrogen atom in said C1-C3alkyl can be independently not substituted or substituted with halogen, and hydrogen of said C2-C3alkenyl is not substituted; R3 denotes hydrogen; and R5 is C1 alkyl.
EFFECT: disclosed are novel compounds, an effective method for preparing them, pharmaceutical compositions based thereon, effective for treating or preventing diabetes.
8 cl, 1 tbl, 70 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING DEPHENYLMETHANE DERIVATIVE | 2017 |
|
RU2797392C2 |
METHOD OF PRODUCING DEPHENYLMETHANE DERIVATIVE | 2023 |
|
RU2814846C1 |
SECONDARY MANNOSIS FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2667060C2 |
MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2678327C2 |
SOLID FORMS (2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZIL)PHENYL)-6-(METHYLTHIO)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL AND METHODS FOR THEIR OBTAINING | 2009 |
|
RU2505543C2 |
COMPOSITIONS COMPRISING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 AND METHODS OF USING THEREOF | 2012 |
|
RU2669921C2 |
C-MANNOSIDE COMPOUNDS USED FOR TREATMENT OF URINARY TRACT INFECTIONS | 2019 |
|
RU2790228C2 |
C-ARYL GLUCOSIDE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF | 2011 |
|
RU2606501C2 |
2-CYANOPYRIMIDINE-4-YL CARBAMATE, OR A UREA DERIVATIVE, OR ITS SALT AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2019 |
|
RU2788740C2 |
PYRAZOLOPYRIMIDINE DERIVATIVES AS A KINASE INHIBITOR | 2017 |
|
RU2714206C1 |
Authors
Dates
2020-12-21—Published
2017-01-03—Filed